January 16, 2012 – The American Food and Drug Administration ( FDA) released on January 13, 2012 the following drug safety communication: _________________ ISSUE: FDA notified healthcare professionals that two additional cases of progressive multifocal leukoencephalopathy (PML), a rare but serious …

Drug Safety Communication on Brentuximab Vedotin [Adcetris] – Progressive Multifocal Leukoencephalopathy (PML) and Pulmonary Toxicity Read more »